These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3345153)

  • 1. Quantitative assessment of postsurgical breakdown of the blood-aqueous barrier following administration of 0.5% ketorolac tromethamine solution. A double-masked, paired comparison with vehicle-placebo solution study.
    Flach AJ; Graham J; Kruger LP; Stegman RC; Tanenbaum L
    Arch Ophthalmol; 1988 Mar; 106(3):344-7. PubMed ID: 3345153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The quantitative effect of 0.5% ketorolac tromethamine solution and 0.1% dexamethasone sodium phosphate solution on postsurgical blood-aqueous barrier.
    Flach AJ; Kraff MC; Sanders DR; Tanenbaum L
    Arch Ophthalmol; 1988 Apr; 106(4):480-3. PubMed ID: 3355415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of ketorolac tromethamine in reducing postoperative inflammation: double-mask parallel comparison with dexamethasone.
    Flach AJ; Jaffe NS; Akers WA
    Ann Ophthalmol; 1989 Nov; 21(11):407-11. PubMed ID: 2619149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of ketorolac tromethamine solution 0.5% in reducing postoperative inflammation after cataract extraction and intraocular lens implantation.
    Flach AJ; Lavelle CJ; Olander KW; Retzlaff JA; Sorenson LW
    Ophthalmology; 1988 Sep; 95(9):1279-84. PubMed ID: 3062540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety profile of ketorolac 0.5% ophthalmic solution in the prevention of surgically induced miosis during cataract surgery.
    Stewart R; Grosserode R; Cheetham JK; Rosenthal A
    Clin Ther; 1999 Apr; 21(4):723-32. PubMed ID: 10363737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ketorolac tromethamine 0.5% ophthalmic solution in the treatment of moderate to severe ocular inflammation after cataract surgery: a randomized, vehicle-controlled clinical trial.
    Heier J; Cheetham JK; Degryse R; Dirks MS; Caldwell DR; Silverstone DE; Rosenthal A
    Am J Ophthalmol; 1999 Mar; 127(3):253-9. PubMed ID: 10088733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the efficacy and safety of ketorolac tromethamine 0.5% and prednisolone acetate 1% after cataract surgery.
    Simone JN; Pendelton RA; Jenkins JE
    J Cataract Refract Surg; 1999 May; 25(5):699-704. PubMed ID: 10330648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of ketorolac tromethamine 0.5% ophthalmic solution for chronic aphakic and pseudophakic cystoid macular edema.
    Flach AJ; Dolan BJ; Irvine AR
    Am J Ophthalmol; 1987 Apr; 103(4):479-86. PubMed ID: 3551617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ketorolac tromethamine in the maintenance of intraoperative mydriasis.
    Gupta VP; Dhaliwal U; Prasad N
    Ophthalmic Surg Lasers; 1997 Sep; 28(9):731-8. PubMed ID: 9304635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of 0.4% ketorolac tromethamine ophthalmic solution versus 0.5% ketorolac tromethamine ophthalmic solution after phacoemulsification and intraocular lens implantation.
    Sandoval HP; De Castro LE; Vroman DT; Solomon KD
    J Ocul Pharmacol Ther; 2006 Aug; 22(4):251-7. PubMed ID: 16910866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ketorolac, prednisolone, and dexamethasone for postoperative inflammation.
    Ostrov CS; Sirkin SR; Deutsch WE; Masi RJ; Chandler JW; Lindquist TD
    Clin Ther; 1997; 19(2):259-72. PubMed ID: 9152565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effects of ketorolac 0.5% or diclofenac 0.1% ophthalmic solutions on inflammation after cataract surgery.
    Flach AJ; Dolan BJ; Donahue ME; Faktorovich EG; Gonzalez GA
    Ophthalmology; 1998 Sep; 105(9):1775-9. PubMed ID: 9754191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of flurbiprofen 0.03% eye drops on the blood aqueous barrier in extracapsular cataract extraction with IOL implantation.
    Diestelhorst M; Aspacher F; Konen W; Krieglstein GK
    Int Ophthalmol; 1991 Mar; 15(2):69-73. PubMed ID: 2022441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analgesic efficacy and safety of nonpreserved ketorolac tromethamine ophthalmic solution following radial keratotomy. Ketorolac Radial Keratotomy Study Group.
    Yee RW
    Am J Ophthalmol; 1998 Apr; 125(4):472-80. PubMed ID: 9559732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical ketorolac tromethamine 0.5% ophthalmic solution in ocular inflammation after cataract surgery.
    Solomon KD; Cheetham JK; DeGryse R; Brint SF; Rosenthal A
    Ophthalmology; 2001 Feb; 108(2):331-7. PubMed ID: 11158809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of ketorolac tromethamine 0.5% and loteprednol etabonate 0.5% for inflammation after phacoemulsification: prospective randomized double-masked study.
    Holzer MP; Solomon KD; Sandoval HP; Vroman DT
    J Cataract Refract Surg; 2002 Jan; 28(1):93-9. PubMed ID: 11777716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized double-masked trial comparing ketorolac tromethamine 0.5%, diclofenac sodium 0.1%, and prednisolone acetate 1% in reducing post-phacoemulsification flare and cells.
    el-Harazi SM; Ruiz RS; Feldman RM; Villanueva G; Chuang AZ
    Ophthalmic Surg Lasers; 1998 Jul; 29(7):539-44. PubMed ID: 9674003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylaxis of aphakic cystoid macular edema without corticosteroids. A paired-comparison, placebo-controlled double-masked study.
    Flach AJ; Stegman RC; Graham J; Kruger LP
    Ophthalmology; 1990 Oct; 97(10):1253-8. PubMed ID: 2243674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of prednisolone 1%, rimexolone 1% and ketorolac tromethamine 0.5% after cataract extraction: a prospective, randomized, double-masked study.
    Hirneiss C; Neubauer AS; Kampik A; Schönfeld CL
    Graefes Arch Clin Exp Ophthalmol; 2005 Aug; 243(8):768-73. PubMed ID: 15756571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The morphine sparing effect of ketorolac tromethamine. A study of a new, parenteral non-steroidal anti-inflammatory agent after abdominal surgery.
    Gillies GW; Kenny GN; Bullingham RE; McArdle CS
    Anaesthesia; 1987 Jul; 42(7):727-31. PubMed ID: 3307518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.